Park Medi World (NSE:PARKHOSPS) Marketable Securities: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:PARKHOSPS Park Medi World Ltd NSE:PARKHOSPS
23 GF Score
Price ₹276.65
! 4 Warning Signs
View Full Analysis

What is Park Medi World Marketable Securities?

Park Medi World NSE:PARKHOSPS -1.67% 23 Marketable Securities is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:PARKHOSPS with a GF Score™ of 23/100. The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Park Medi World's Marketable Securities for the quarter that ended in Jun. 2026 was ₹0 Mil.

Park Medi World's annual Marketable Securities declined from Mar. 2024 (₹3,133 Mil) to Mar. 2025 (₹2,578 Mil) and declined from Mar. 2025 (₹2,578 Mil) to Mar. 2026 (₹2,247 Mil).

Park Medi World  (NSE:PARKHOSPS) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Park Medi World Marketable Securities Related Terms

Park Medi World Marketable Securities Historical Data

* Premium members only.

The historical data trend for Park Medi World's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Park Medi World Marketable Securities Chart

Park Medi World Annual Data
Trend Mar23 Mar24 Mar25 Mar26
Marketable Securities
1,026.08 3,133.37 2,577.54 2,246.83

Park Medi World Quarterly Data
Mar23 Mar24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only 0.00 1,111.24 0.00 2,246.83 0.00
NSE:PARKHOSPS
23GF Score
Park Medi World Ltd NSE:PARKHOSPS
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Park Medi World Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of ₹0 Mil mean?
Park Medi World (NSE:PARKHOSPS) has a Marketable Securities of ₹0 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Park Medi World and its competitors.
Is Park Medi World's Marketable Securities too high?
Park Medi World's current Marketable Securities is ₹0 Mil. Overall, Park Medi World has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Park Medi World's Marketable Securities compare to HCA and THC?
Park Medi World's Marketable Securities of ₹0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Park Medi World and its competitors. Park Medi World's current Marketable Securities is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Park Medi World stock overvalued right now?
Park Medi World (NSE:PARKHOSPS) has a current Marketable Securities of ₹0 Mil. The current Marketable Securities is ₹0 Mil. Park Medi World's overall GF Score™ is 23/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Park Medi World (NSE:PARKHOSPS), the current Marketable Securities is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Park Medi World Business Description

Other Exchanges 544645:India
Address Plot no. 521, Park Tower, Udyog Vihar Phase 3, Gurugram, HR, IND, 122 022
Park Medi World Ltd is a private hospital chain in North India with an aggregate bed capacity of 3,000 beds, and a private hospital chain in terms of bed capacity in Haryana with 1,600 beds. The company operates a network of 14 NABH accredited multi-super specialty hospitals under the Park brand, of which eight hospitals are also NABL accredited, with eight hospitals in Haryana, one hospital in New Delhi, three hospitals in Punjab and two hospitals in Rajasthan, each committed to providing high-quality and affordable medical services across a diverse range of specialties. It offers over 30 super specialty and specialty services, including internal medicine, neurology, urology, gastroentereology, general surgery, orthopedics and oncology.
23GF Score

Get the complete analysis for NSE:PARKHOSPS

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹276.65
Price